Vaccine Manufacturing Practices and Residual Vaccine Contaminants
A trio of recent publications in NEURON reports the presence of hundreds of diverse de novo gene mutations indicating that ASD may be a disease of genomic instability, with a significant environmental component. US birthyear changepoints in AD are apparent in 1980, 1988 and 1996, coinciding with the switch to or introduction of childhood vaccines contaminated with human endogenous retrovirus K (HERVK) and human fetal DNA fragments. HERVK and human fetal DNA contaminants could contribute to the genomic instability of ASD demonstrated by de novo mutations.
Theresa Deisher, PhD, PhD
Dr. Deisher obtained her PhD in Cellular and Molecular Physiology from Stanford University and has spent over 20 years in commercial biotechnology, with companies including Genentech, Repligen, ZymoGenetics, Immunex and Amgen, prior to founding AVM Biotechnology and Sound Choice Pharmaceutical Institute. Dr. Deisher is an inventor on 22 issued US patents, and her discoveries have led to clinical trials in osteoarthritis, cartilage repair, and surgical bleeding. Dr. Deisher was the first person to discover and patent adult cardiac derived pluripotent stem cells.
